Your browser doesn't support javascript.
loading
Preparation and structure-activity relationship of novel P1/P1'-substituted cyclic urea-based human immunodeficiency virus type-1 protease inhibitors.
Nugiel, D A; Jacobs, K; Kaltenbach, R F; Worley, T; Patel, M; Meyer, D T; Jadhav, P K; De Lucca, G V; Smyser, T E; Klabe, R M; Bacheler, L T; Rayner, M M; Seitz, S P.
Affiliation
  • Nugiel DA; Dupont Merck Pharmaceutical Company, Wilmington, Delaware 19880-0500, USA.
J Med Chem ; 39(11): 2156-69, 1996 May 24.
Article in En | MEDLINE | ID: mdl-8667359
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Azepines / Urea / HIV Protease / HIV Protease Inhibitors Limits: Humans Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 1996 Document type: Article Affiliation country: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Azepines / Urea / HIV Protease / HIV Protease Inhibitors Limits: Humans Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 1996 Document type: Article Affiliation country: United States